News and blogs
34 results found.
A new era of funding for blood cancer research
We’re thrilled to introduce the Transformational Research Awards. A major step forward in our mission to fund pioneering research to transform blood cancer treatment for all ages.
AI: it’s not all “robot uprisings” - A true force for good in the healthcare space
Read more how blood cancer researcher Professor Daniel Royston is using AI to help improve the diagnosis and treatment of blood cancer.
Our highlights from the 2024 ASH conference
Read more on highlights from the 2024 annual American Society of Haematology (ASH) conference
From despair to hope: The Matthew Wilson Multiple Myeloma Fund
Matthew Wilson establishes the Matthew Wilson Multiple Myeloma Fund (MWMMF) at Blood Cancer UK.
What we can achieve with £1 million
We're proud to announce We’ve invested over £1 million funding five research projects, across five different blood cancers
A new dawn for clinical trials
A new dawn for clinical trials to get us to a place where no lives are lost to blood cancer
Paxlovid rebound - what we know
Paxlovid rebound is when people recover from covid-19 after taking a course of Paxlovid tablets, but then the infection seems to come back. Find out what this means for people offered treatment with Paxlovid.
Evusheld available in the UK to buy privately
Evusheld is available privately in the UK. Here’s what we know about how to access it.
Latest updates from the Covid-19 Vaccine Research Collaborative
Find out the latest information on the Covid-19 Vaccine Research Collaborative from Blood Cancer UK.
How we helped Covid booster vaccine research
Discover how Blood Cancer UK played a key part in Covid booster vaccine research for immune compromised patients, helping to create the OCTAVE-DUO study.
Can a blood test detect cancer?
Learn more about a new blood test that looks at cell-free DNA (cfDNA) that could detect cancers earlier.
Five reasons for people with blood cancer to be hopeful about the Covid pandemic
Find out why better treatments and vaccine efficacy should make people with blood cancer more hopeful about the Covid pandemic.
Do people with myeloma have an antibody response to the Covid vaccine?
Read Blood Cancer UK's article on the study into the number of people with myeloma who had some kind of antibody response to the Covid vaccine.
How can I get involved in blood cancer research?
Find out how you can get involved in blood cancer research to help us beat blood cancer.
Should people with blood cancer get an antibody test?
Read more about what people with blood cancer should know about antibody tests and the Covid vaccine.
How was the coronavirus vaccine created?
Learn how the coronavirus vaccines were made, including information on clinical trials, vaccine approvals and long-term side effects.
The coronavirus vaccine: what you need to know
We outline what we know about the potential coronavirus vaccines, and explore what they could mean for people with blood cancer.
How does the coronavirus affect people with blood cancer?
Blood Cancer UK are funding vital research that will explore how different types of blood cancer might affect someone’s individual level of risk from coronavirus.
New research hope for those with a rare type of leukaemia
Blood Cancer UK research fellow, Dr Marc Mansour and his team, have come to understand more about why some types of T-cell acute lymphoblastic leukaemia (T-ALL) stop responding to chemotherapy, and how we might overcome it in the future.
Leukaemia - how we can use information to treat it
Why finding about how we get leukaemia in the first place is so important for developing new treatments.
